Despite reports showing that IRF4 plays an oncogenic role in promoting lymphomagenesis via downregulation of BCL2 family proteins, such as BIM and BMF,41 we revealed that IRF4 directly interacts with BCL2 in DLBCL. Here, BCL2 is linked to diffuse large B-cell lymphoma.